Literature DB >> 5700487

[Rhodiolosid, a new glycoside from Rhodiola rosea and its pharmacological properties].

A S Ssaratikov, E A Krasnov, L A Chnikina, L M Duvidson, M I Sotova, T F Marina, M F Nechoda, R A Axenova, S G Tscherdinzeff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5700487

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


× No keyword cloud information.
  5 in total

1.  Simultaneous Determination of 78 Compounds of Rhodiola rosea Extract by Supercritical CO2-Extraction and HPLC-ESI-MS/MS Spectrometry.

Authors:  Alexander M Zakharenko; Mayya P Razgonova; Konstantin S Pikula; Kirill S Golokhvast
Journal:  Biochem Res Int       Date:  2021-07-06

Review 2.  Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity.

Authors:  Alexander Panossian; Georg Wikman
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-19

3.  Assessing the Quality and Potential Efficacy of Commercial Extracts of Rhodiola rosea L. by Analyzing the Salidroside and Rosavin Content and the Electrophysiological Activity in Hippocampal Long-Term Potentiation, a Synaptic Model of Memory.

Authors:  Wilfried Dimpfel; Leonie Schombert; Alexander G Panossian
Journal:  Front Pharmacol       Date:  2018-05-24       Impact factor: 5.810

4.  Synthesis of some phenylpropanoid glycosides (PPGs) and their acetylcholinesterase/xanthine oxidase inhibitory activities.

Authors:  Xiao-Dong Li; Shuai-Tao Kang; Guo-Yu Li; Xian Li; Jin-Hui Wang
Journal:  Molecules       Date:  2011-04-28       Impact factor: 4.411

5.  The impact of Rhodiola rosea on the gut microbial community of Drosophila melanogaster.

Authors:  Khachik E Labachyan; Dara Kiani; Evgueni A Sevrioukov; Samuel E Schriner; Mahtab Jafari
Journal:  Gut Pathog       Date:  2018-03-20       Impact factor: 4.181

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.